ReviewFrontiers in pharmacology2023
Sacubitril/valsartan: research progress of multi-channel therapy for cardiorenal syndrome.
Shuangcui Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it